scholarly journals PHP9 THE IMPACT OF MAIL ORDER PHARMACY IN DRUG UTILIZATION AND REIMBURSEMENT IN A LARGE RETIREMENT SYSTEM

2007 ◽  
Vol 10 (3) ◽  
pp. A24 ◽  
Author(s):  
E Seoane-Vazquez ◽  
R Rodriguez-Monguio ◽  
J Visaria
2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S470-S470
Author(s):  
Josh Havens ◽  
Moses New-Aaron ◽  
Yangyang Gao ◽  
Qingfeng He ◽  
Fadul Nada ◽  
...  

Abstract Background People with HIV (PWH) utilize various pharmacy types beyond the traditional local pharmacy including mail order and specialty pharmacies. Some pharmacies often provide additional adherence services such as refill reminders, expedited delivery, and adherence packaging. Limited data are available describing the relationship between pharmacy type and HIV viral suppression (VS). We evaluated the impact of pharmacy type on VS. Methods We conducted a single-center, retrospective cohort study of PWH (≥19 years) receiving care at a Midwestern HIV clinic between January 1, 2018, and December 31, 2018, with at least 1 HIV RNA reading during the study period. We collected sociodemographic information, ART regimen, adherence (PDC—percentage of days covered), and clinical characteristics. Patients were stratified by pharmacy type: local (traditional pharmacy without adherence services), local specialty (traditional pharmacy with adherence services and same-day, couriered delivery), and mail order (mail order pharmacy with or without adherence services). Pearson Chi-squared tests and binary logistic regression were used to examine the effect of pharmacy type on VS (HIV viral load ≤50 copies/mL). Results A total of 1014 patients met study criteria; 164 (16%) utilized a local, 720 (71%) local specialty, and 130 (13%) mail order. VS rates were similar between pharmacy types: local (91%), semi-specialty local (88%), and mail order (96%). After adjusting for sociodemographic characteristics, ART regimen, ART adherence and other clinical characteristics, there was no association between pharmacy type and VS when comparing local and mail to local specialty pharmacy types (local—aOR: 0.98, 95% CI, 0.46–2.12; mail—aOR: 1.65, 95% CI, 0.46–6.0). Factors found to be negatively associated with VS were single marital status (aOR: 0.49; 95% CI, 0.24–0.95), current or historical opportunistic infection (aOR: 0.51; 95% CI, 0.26–0.99), and usage of a multiclass or dual ART regimen (aOR: 0.40; 95% CI, 0.16–0.98). Conclusion Despite additional services offered by some pharmacies, no differences were observed in HIV VS between pharmacy types. Disclosures All authors: No reported disclosures.


2011 ◽  
Vol 27 (1) ◽  
pp. e41-e50 ◽  
Author(s):  
Jay Visaria ◽  
Enrique Seoane-Vazquez ◽  
Sheryl L. Szeinbach ◽  
Rosa Rodriguez-Monguio

2007 ◽  
Vol 7 (1) ◽  
Author(s):  
Satish Valluri ◽  
Enrique Seoane-Vazquez ◽  
Rosa Rodriguez-Monguio ◽  
Sheryl L Szeinbach

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2322-PUB ◽  
Author(s):  
JULIE SCHMITTDIEL ◽  
CASSONDRA MARSHALL ◽  
DEANNE WILEY ◽  
CHRISTOPHER V. CHAU ◽  
CONNIE M. TRINACTY ◽  
...  

1989 ◽  
Vol 29 (8) ◽  
pp. 22-25
Author(s):  
Martin J. Jinks ◽  
Lynette M. Evenson ◽  
R. Keith Campbell ◽  
Stan Bye

Pneumologie ◽  
2020 ◽  
Vol 74 (03) ◽  
pp. 149-158
Author(s):  
P. Kardos ◽  
F. Geiss ◽  
J. Simon ◽  
C. Franken ◽  
U. Butt ◽  
...  

Abstract Introduction Inhalative treatments with metered dose aerosols and dry powder inhalers are the backbone of the pharmacotherapy for asthma and COPD. In the last decade many new and generic inhalative bronchodilators were launched at the German market, both monotherapies and fixed dose double bronchodilator (LABA/LAMA, beta adrenergic and antimuscarinic) or LABA and inhaled corticosteroid (ICS) and triple (LABA/LAMA/ICS) combinations. According to two surveys in 2015 among respiratory physicians we expected a high proportion of patients receiving duplicate prescriptions, e. g. a fixed dose new LABA/LAMA combination in addition to an existing ICS/LABA fixed dose combination. Methodology We searched the database of a large mail order pharmacy (DocMorris) to identify duplicate prescriptions of inhalative drugs for a patient by the same or by two or more different physicians during a 3 months period. Results Unexpectedly, we found as little as around 1 % duplicate prescriptions for the same patient. Duplicate prescriptions involving combination products were found to be much more common than duplicate prescriptions of different mono-products. Irrespective the low percentage number of all prescriptions we saw in just one large mail order pharmacy several thousands of erroneous prescriptions. Conclusion At least in the setting of this mail order pharmacy duplicate (i. e. contraindicated and potentially dangerous) prescriptions are relatively rare. Prescribers and pharmacists should be aware of the issue of duplicates – especially when prescribing or filling prescriptions with combination products.


2009 ◽  
Vol 12 (3) ◽  
pp. A80
Author(s):  
E Patorno ◽  
A Margulis ◽  
S Cai ◽  
JJ Gagne ◽  
BP Geisler ◽  
...  

1989 ◽  
Vol 29 (8) ◽  
pp. 26-27
Author(s):  
Sara Martin

Sign in / Sign up

Export Citation Format

Share Document